Search Results - "Marincola, F. M."
-
1
EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN
Published in Oncogene (23-04-2015)“…The epithelial-mesenchymal transition (EMT) is crucial to cancer progression and metastasis. Although multiple cellular miRNAs have been identified to regulate…”
Get full text
Journal Article -
2
Immunoscore and Immunoprofiling in cancer: an update from the melanoma and immunotherapy bridge 2015
Published in Journal of translational medicine (20-09-2016)“…The fifth "Melanoma Bridge Meeting" took place in Naples, December 1-5th, 2015. The main topics discussed at this meeting were: Molecular and Immuno advances,…”
Get full text
Journal Article Conference Proceeding -
3
CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2
Published in British journal of cancer (29-10-2013)“…Background: Adoptive therapy with tumour-infiltrating lymphocytes (TILs) induces durable complete responses (CR) in ∼20% of patients with metastatic melanoma…”
Get full text
Journal Article -
4
Targeting proapoptotic protein BAD inhibits survival and self-renewal of cancer stem cells
Published in Cell death and differentiation (01-12-2014)“…Emerging evidence suggests that the resistance of cancer stem cells (CSC) to many conventional therapies is one of the major limiting factors of cancer therapy…”
Get full text
Journal Article -
5
Consistent Cytotoxic-T-Lymphocyte Targeting of Immunodominant Regions in Human Immunodeficiency Virus across Multiple Ethnicities
Published in Journal of Virology (01-03-2004)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
6
IRF-1 responsiveness to IFN-γ predicts different cancer immune phenotypes
Published in British journal of cancer (09-07-2013)“…Background: Several lines of evidence suggest a dichotomy between immune active and quiescent cancers, with the former associated with a good prognostic…”
Get full text
Journal Article -
7
Cancer Immunotherapy With Peptide-Based Vaccines: What Have We Achieved? Where Are We Going?
Published in JNCI : Journal of the National Cancer Institute (05-06-2002)“…Many human tumor-associated antigens (TAAs) have recently been identified and molecularly characterized. When bound to major histocompatibility complex…”
Get full text
Journal Article -
8
Inherited polymorphisms in the RNA-mediated interference machinery affect microRNA expression and lung cancer survival
Published in British journal of cancer (07-12-2010)“…Background: MicroRNAs (miRs) have an important role in lung carcinogenesis and progression. Single-nucleotide polymorphisms (SNPs) in genes involved in miR…”
Get full text
Journal Article -
9
High-fidelity mRNA amplification for gene profiling
Published in Nature biotechnology (01-04-2000)“…The completion of the Human Genome Project has made possible the comprehensive analysis of gene expression, and cDNA microarrays are now being employed for…”
Get full text
Journal Article -
10
Epstein-Barr virus microRNAs and lung cancer
Published in British journal of cancer (12-07-2011)“…Background: We conducted the first analysis of viral microRNAs (miRNAs) in lung cancer, with a focus on Epstein–Barr virus (EBV). Methods: We evaluated viral…”
Get full text
Journal Article -
11
Advantages of mRNA amplification for microarray analysis
Published in BioTechniques (01-10-2002)“…Expanding applications of cDNA microarrays such as fine needle aspiration biopsy and laser capture microdissection necessitate the ability to perform arrays…”
Get full text
Journal Article -
12
Loss of Functional Beta2-Microglobulin in Metastatic Melanomas From Five Patients Receiving Immunotherapy
Published in JNCI : Journal of the National Cancer Institute (17-01-1996)“…Background: In a subset of patients with metastatic melanoma, T lymphocytes bearing the cell-surface marker CD8 (CD8+ T cells) can cause the regression of even…”
Get full text
Journal Article -
13
Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens
Published in JNCI : Journal of the National Cancer Institute (16-12-1998)“…The characterization of the genes encoding melanoma-associated antigens MART-1 or gp100, recognized by T cells, has opened new possibilities for the…”
Get full text
Journal Article -
14
IL-10 stimulatory effects on human NK cells explored by gene profile analysis
Published in Genes and immunity (01-12-2004)“…The molecular mechanisms underlying the increase of natural killer (NK) cell anticancer activity mediated by interleukin (IL)-10 have not been elucidated. The…”
Get full text
Journal Article -
15
Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin-2 and Interferon Alfa-2b
Published in Journal of clinical oncology (01-03-1999)“…The combination of chemotherapy with immunotherapeutic agents such as interleukin-2 and interferon alfa-2b has been reported to provide improved treatment…”
Get full text
Journal Article -
16
Phase 1 study in patients with metastatic melanoma of immunization with Dendritic cells presenting epitopes derived from the melanoma-associated antigens MART-1 and gp100
Published in Journal of immunotherapy (1997) (01-07-2000)“…Dendritic cells (DCs) have been shown to enhance anti-tumor immune responses in several preclinical models. Furthermore, DC-like function can be elicited from…”
Get full text
Journal Article -
17
Cell-mediated immunological responses in cervical and vaginal cancer patients immunized with a lipidated epitope of human papillomavirus type 16 E7
Published in Clinical cancer research (01-09-1998)“…Human papillomavirus (HPV) infection has been causally associated with cervical cancer. We tested the effectiveness of an HLA-A*0201-restricted, HPV-16 E7…”
Get full text
Journal Article -
18
Immunization against epitopes in the human melanoma antigen gp100 following patient immunization with synthetic peptides
Published in Cancer research (Chicago, Ill.) (15-10-1996)“…gp1OO is a melanocytic lineage-specific antigen recognized by tumor-infiltrating lymphocytes, the adoptive transfer of which is associated with tumor…”
Get full text
Journal Article -
19
Real-Time Quantitative Polymerase Chain Reaction Assessment of Immune Reactivity in Melanoma Patients After Tumor Peptide Vaccination
Published in JNCI : Journal of the National Cancer Institute (16-08-2000)“…Background: Monitoring the immune response to epitope-specific vaccination in cancer patients is important for vaccine development. The traditional method, in…”
Get full text
Journal Article -
20
Intensity of the Vaccine-Elicited Immune Response Determines Tumor Clearance
Published in The Journal of immunology (1950) (01-01-2002)“…Tumor Ag-specific vaccines used for cancer immunotherapy can generate specific CD8 responses detectable in PBMCs and in tumor-infiltrating lymphocytes…”
Get full text
Journal Article